These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32744431)

  • 1. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
    Li Y; Zhu Z; Ma F; Xue L; Tian Y
    Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
    Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
    Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
    J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.
    Ozden S; Ozgen Z; Ozyurt H; Gemici C; Yaprak G; Tepetam H; Mayadagli A
    World J Gastroenterol; 2015 Jan; 21(4):1222-33. PubMed ID: 25632196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric signet ring cell adenocarcinoma: A distinct entity].
    Tabouret T; Dhooge M; Rouquette A; Brezault C; Beuvon F; Chaussade S; Coriat R
    Presse Med; 2014 Apr; 43(4 Pt 1):353-7. PubMed ID: 24440764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study.
    Yeh JM; Tramontano AC; Hur C; Schrag D
    Gastric Cancer; 2017 Sep; 20(5):811-824. PubMed ID: 28205057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
    Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
    Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 12. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
    Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
    Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.
    Pokala SK; Zhang C; Chen Z; Gamboa AM; Cristofaro SL; Keilin SA; Cai Q; Willingham FF
    J Gastrointest Surg; 2018 Apr; 22(4):569-577. PubMed ID: 29313289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
    Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
    Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy.
    Jácome AA; Wohnrath DR; Scapulatempo Neto C; Fregnani JH; Quinto AL; Oliveira AT; Vazquez VL; Fava G; Martinez EZ; Santos JS
    Gastric Cancer; 2013 Apr; 16(2):233-8. PubMed ID: 22740060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario.
    Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N
    J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 20. Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study.
    Xie Y; Song X; Dong W; Jin H; Ni Z; Li X; Huang H
    Biomed Res Int; 2022; 2022():1565207. PubMed ID: 35141330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.